- Momordicine-I, a Bitter Melon Bioactive Metabolite, Displays Anti-Tumor Activity in Head and Neck Cancer Involving c-Met and Downstream Signaling
Subhayan Sur et al, 2021, Cancers CrossRef - Trichothecin Inhibits Cancer-Related Features in Colorectal Cancer Development by Targeting STAT3
Xin Qi et al, 2020, Molecules CrossRef - Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy
Mahdi Eskandarian Boroujeni et al, 2022, Frontiers in Immunology CrossRef - Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs
Martyna Plens-Galaska et al, 2018, Frontiers in Immunology CrossRef - Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance
Megha Budhwani et al, 2018, Frontiers in Oncology CrossRef - Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease
Malgorzata Szelag et al, 2016, Oncotarget CrossRef